entertainment -WSS

entertainment

author：focus 2025-09-30 15:22:22 - browse：89

President Joe Biden speaks and gestures at a podium outdoor — In addition to medical devices, the United States will raise tariffs on $18 billion worth of products including electric vehicles, batteries, and semiconductors. MANDEL NGAN/AFP via Getty Images

WASHINGTON — The Biden administration announced Tuesday that it’s raising taxes on a range of imported products from China, including syringes, needles, and surgical gloves.

Pitched as a plan to support American workers, the tariffs are meant to protect domestic manufacturers from China’s “unfair trade practices” and “artificially low-priced exports.” In addition to medical devices, the United States will raise tariffs on $18 billion worth of products including electric vehicles, batteries, and semiconductors.

Related: Drug supplies for millions would be jeopardized by U.S. crackdown on China biopharma industry, trade group says

The inclusion of syringes comes after the Food and Drug Administration’s repeated warnings to U.S. medical providers about quality issues with plastic syringes from China. The agency first alerted consumers in November 2023 about leaks and breaks associated with Chinese syringes. In March, the FDA called attention to three warning letters it sent to firms in China for selling syringes that had not received FDA clearance. It has since sent a warning letter to Cardinal Health.

STAT+ Exclusive Story

Already have an account? Log in

This article is exclusive to STAT+ subscribers

Unlock this article — plus daily intelligence on Capitol Hill and the life sciences industry — by subscribing to STAT+.

Already have an account? Log in

Monthly

$39

Totals $468 per year

$39/month Get Started

Totals $468 per year

Starter

$30

for 3 months, then $39/month

$30 for 3 months Get Started

Then $39/month

Annual

$399

Save 15%

$399/year Get Started

Save 15%

11+ Users

Custom

Savings start at 25%!

Request A Quote Request A Quote

Savings start at 25%!

2-10 Users

$300

Annually per user

$300/year Get Started

$300 Annually per user

View All Plans

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： How to save PrEP access — and even expand it
Next article： Senators push IRS to launch nonprofit hospital probe

focus

WSS

Listen: Wegovy in the brain & pivotal Alzheimer's data

In early work, researchers turn to CRISPR to treat Alzheimer's

Medicare has a new plan to address drug shortages

Google and Epic fight stronger regulation of AI in health care

Treatments for cramps don't cut it. Why aren't there better options?

Idaho college killings prosecutors challenge defense's grand jury claims

explore

entertainment

Related: Drug supplies for millions would be jeopardized by U.S. crackdown on China biopharma industry, trade group says

This article is exclusive to STAT+ subscribers

Unlock this article — plus daily intelligence on Capitol Hill and the life sciences industry — by subscribing to STAT+.

Wikipedia

Drug repurposing or repositioning? The language matters

Senators push IRS to launch nonprofit hospital probe

Medical leaders decry Supreme Court decision on affirmative action

Aspartame and sugar

FDA approval of Sarepta Duchenne genetic therapy gives me hope

Megan Rapinoe shares emotional post following US Women's World Cup exit

Over 800 arrested across France in 3rd night of riots after fatal police shooting of teen

Key House panel plots a new health care package

Hepatitis C has a cure — but many Americans still lack access to it

Aspartame and sugar

Wikipedia

Medicare to cover more brain scans for Alzheimer’s patients

Why hospitals are withdrawing from US News rankings

As digital health tech proliferates, a new institute aims to cut through hype

Sanofi seeks simpler, safer CRISPR sickle cell cure

Biden administration begins canceling student loan debt for 804,000 borrowers

What to know about the judge who will handle the Trump case

focus

focus

focus

hotspot